Latest Period
n/a
Security Snapshot
Scinai Immunotherapeutics Ltd. - ADSs (BVXV) Institutional Ownership
CUSIP: 09073Q105
13F Institutional Holders and Ownership History from Q2 2015 to Q4 2022
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / ADSs
- Symbol
- BVXV
- Shares outstanding
- 592,878
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BVXV - Scinai Immunotherapeutics Ltd. - ADSs is tracked under CUSIP 09073Q105.
- Latest finished 13F holder period is not available.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 10 to 0 between Q3 2022 and Q4 2022.
- SEC-reported value moved from $153,000 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
09073Q105
Latest holder period
n/a
13F holders
13D/G owners
1
CIK / CUSIP context first
BVXV full holder history
Scinai Immunotherapeutics Ltd. SEC filings
Scinai Immunotherapeutics Ltd. company facts
Scinai Immunotherapeutics Ltd. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09073Q105:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
BVXV
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 4.9% | $26,727 | 29,051 | SABBY MANAGEMENT, LLC | 31 Dec 2024 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
31
Latest
n/a
Rows shown
1-25 of 31
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2022 Q4 | 0 | $0 | -$153,000 | 0 | |
| 2022 Q3 | 209,677 | $153,000 | -$107,274 | $0.73 | 10 |
| 2022 Q2 | 333,825 | $389,000 | -$12,455 | $1.17 | 13 |
| 2022 Q1 | 328,283 | $541,300 | -$97,445 | $1.66 | 15 |
| 2021 Q4 | 335,947 | $789,000 | +$204,452 | $2.35 | 13 |
| 2021 Q3 | 253,999 | $558,000 | -$196,362 | $2.20 | 13 |
| 2021 Q2 | 311,298 | $891,000 | -$9,852 | $2.86 | 15 |
| 2021 Q1 | 283,618 | $1,077,000 | +$263,027 | $3.79 | 17 |
| 2020 Q4 | 221,471 | $622,000 | -$16,795,397 | $2.81 | 10 |
| 2020 Q3 | 539,410 | $21,088,000 | +$2,404,448 | $39.10 | 18 |
| 2020 Q2 | 506,304 | $11,519,000 | +$2,223,472 | $22.75 | 14 |
| 2020 Q1 | 404,424 | $3,114,000 | -$681,032 | $7.70 | 7 |
| 2019 Q4 | 476,956 | $4,430,000 | +$658,000 | $9.20 | 11 |
| 2019 Q3 | 405,665 | $2,410,000 | $5.72 | 7 | |
| 2019 Q2 | 405,665 | $2,337,000 | -$63,080 | $5.76 | 7 |
| 2019 Q1 | 417,334 | $2,266,000 | -$139,526 | $5.43 | 9 |
| 2018 Q4 | 446,374 | $2,129,000 | +$105,507 | $4.77 | 10 |
| 2018 Q3 | 448,784 | $2,513,000 | +$7,535 | $5.60 | 11 |
| 2018 Q2 | 447,247 | $2,981,000 | -$159,059 | $6.67 | 11 |
| 2018 Q1 | 475,746 | $2,582,000 | -$55,242 | $5.42 | 14 |
| 2017 Q4 | 496,218 | $2,606,000 | +$130,259 | $5.33 | 11 |
| 2017 Q3 | 106,181 | $689,000 | +$555,135 | $7.14 | 8 |
| 2017 Q2 | 28,497 | $164,000 | -$254,500 | $8.57 | 5 |
| 2017 Q1 | 72,719 | $366,000 | +$221,000 | $5.79 | 5 |
| 2016 Q4 | 39,000 | $102,000 | -$12,000 | $3.35 | 3 |